Spreadsheet: 08124e56-c839-4826-a84f-0e8d59436c7f
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
FMPP | Test | FMPP | Myocarditis/Pericarditis Panel | Myocarditis/Pericarditis Panel | Complement Fixation (CF)/Immunoflourescence Assay (IFA) | Plain, Red-Top or serum gel tube: Red |  |  | 3 | mL | Container/Tube: Preferred: Red top Acceptable: Serum gel [NAME]: 3 mL | 2 mL | Hemolysis	Mild OK; Gross OK Thawing	Warm OK; Cold OK Lipemia	Mild OK; [NAME] OK Icterus	NA Other	NA | MYOCARDITIS-PERICARDITIS PANEL    [NAME]) ANTIBODIES, SERUM       REFERENCE RANGE: <1:8            INTERPRETIVE CRITERIA:                    <1:8  Antibody Not Detected                  > or = 1:8  Antibody Detected        Single titers of > or = 1:32 are indicative of recent infection. Titers of 1:8 or 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.   This test was developed and its performance characteristics have been determined by Focus Diagnostics. Performance characteristics refer to the analytical performance of the test.    ECHOVIRUS ANTIBODIES, SERUM           REFERENCE RANGE: <1:8             INTERPRETIVE CRITERIA:                          <1:8  Antibody Not Detected                        > or = 1:8  Antibody Detected        Single titers > or = 1:32 are indicative of recent infection. Titers of 1:8 and 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis. There is considerable crossreactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype.         This test was developed and its performance characteristics have been determined by Focus Diagnostics. Performance characteristics refer to the analytical performance of the test.    INFLUENZA TYPES A AND B ANTIBODIES, SERUM        REFERENCE RANGE: <1:8             INTERPRETIVE CRITERIA:        <1:8 Antibody Not Detected        > or = 1:8 Antibody Detected        Single titers of > or = 1:64 are indicative of recent infection. Titers of 1:8 to 1:32 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis.   This test was developed and its performance characteristics have been determined by Focus Diagnostics. Performance characteristics refer to the analytical performance of the test.   CHLAMYDOPHILA PNEUMONIAE ANTIBODIES (IgG, IgA, IgM)        REFERENCE RANGE: IgG <1:64                                         IgA <1:16                                         IgM <1:10   The immunofluorescent detection of specific antibodies to Chlamydophila pneumoniae may be complicated by cross-reactive antibodies, non-specific antibody stimulation, or past exposure to similar organisms such as C. psittaci and Chlamydia trachomatis. IgM titers of 1:10 or greater usually indicate recent infection, and any IgG titer may indicate past exposure. IgA is typically present at low titers during primary infection, but may be elevated in recurrent exposures or in chronic infection.   These assays were developed and their performance characteristics have been determined by Focus Diagnostics. They have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test.         Test Performed by:  Focus Diagnostics, Inc.                                     5785 Corporate Avenue                                     Cypress, CA   90630-4750 | Varies; Monday through Saturday | 1 - 5 days | 3 - 9 days |  | Profile |  |  |  |  | Focus Diagnositics, Inc.
FMPP | [NAME] | SERUM | Serum |  |  |  | Refrigerated | 14 days
FMPP | Billing Component | FMPP |  | Influenza Virus Types A/B |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 86710
FMPP | Billing Component | FMPP |  | enterovirus |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 | 86658
FMPP | Billing Component | FMPP |  | enterovirus |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 | 86658
FMPP | Billing Component | FMPP |  | Gel Diffusion, Qual, each |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 | 86331
FMPP | Billing Component | FMPP |  | Chlamydia, IgM |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 86632
FMPP | Component | CXB_1 | [NAME]) Antibodies, S | [NAME]) Antibodies, S | Complement Fixation (CF) Only orderable as part of a profile. For further information see #91332 "Myocarditis/Pericarditis Panel" |  |  |  | 2 | mL | 3 mL of serum sent refrigerated. Only orderable as part of a profile. For further information see #91332 "Myocarditis/Pericarditis Panel" |  |  |  |  |  |  | 6 | 86658 |  |  | Yes | Yes (Order COXB)
CXB_1 | [NAME] | SERUM | Serum |  |  |  | Refrigerated
CXB_1 | Result | Z2303 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
CXB_1 | Result | Z2304 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
CXB_1 | Result | Z2305 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
CXB_1 | Result | [NAME] | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
CXB_1 | Result | Z2307 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
CXB_1 | Result | Z2308 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMPP | Component | ECH_1 | Echovirus Antibodies, S | Echovirus Antibody Panel, Serum | Only orderable as part of a profile. For further information see #91332 "Myocarditis/Pericarditis Panel" |  |  |  |  |  | Only orderable as part of a profile. For further information see #91332 "Myocarditis/Pericarditis Panel" |  |  |  |  |  |  | 5 | 86658 |  |  | Yes | Yes (Order ECHO)
ECH_1 | [NAME] | SERUM | Serum |  |  |  | Refrigerated
ECH_1 | Result | Z2309 | Echovirus 4 Ab | Echovirus 4 Ab | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
ECH_1 | Result | Z2310 | Echovirus 7 Ab | Echovirus 7 Ab | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
ECH_1 | Result | Z2311 | Echovirus 9 Ab | Echovirus 9 Ab | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
ECH_1 | Result | Z2313 | Echovirus 11 Ab | Echovirus 11 Ab | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
ECH_1 | Result | Z2314 | Echovirus 30 Ab | Echovirus 30 Ab | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMPP | Component | FINFL | Influenza Virus Types A and B Antibody, CF, (Serum) | [NAME] A and B Ab, Serum | Complement Fixation (CF) Only orderable as part of a profile. For further information see #91332 "Myocarditis/Pericarditis Panel" | Plain, Red-Top Tube: Red |  |  | 3 | mL | CAN ONLY BE ORDERED IN THE PANEL 91332 |  |  | REFERENCE RANGE:  <1:8        INTERPRETIVE CRITERIA          <1:8 Antibody Not Detected    > or = 1:8 Antibody Detected        Single titers of > or = 1:64 are indicative of recent infection. Titers of 1:8 to 1:32 may be indicative of  either past or recent infection, since CF antibody levels persist for only a few months. A four-fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis.   This test was developed and its performance characteristics have been determined by Focus Diagnostics. Performance characteristics refer to the analytical performance of the test.  Test Performed by: Focus Diagnostics, Inc.                                        5785 Corporate Ave.                                        Cypress, CA 90630 |  |  |  | 2 | 86710 |  |  | Yes | No
FINFL | [NAME] | SERUM | Serum |  |  |  | Refrigerated | 14 days
FINFL | Result | Z0364 | Influenza A Ab | Influenza A Ab | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FINFL | Result | Z0365 | [NAME] | [NAME] | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FMPP | Component | FCPAB | Chlamydophila Pneumoniae Antibodies (IgG, IgA, IgM) | Chlamydophila pneumoniae Ab IgG/M/A | Only orderable as part of a profile. For further information see #91332 "Myocarditis/Pericarditis Panel" |  |  |  | 1 | mL | See profile 91332 |  |  |  |  |  |  |  | Profile |  |  | Yes | No
FCPAB | [NAME] | SERUM | Serum |  |  |  | Refrigerated | 14 days
FCPAB | Result | Z0553 | C. pneumoniae IgG | C. pneumoniae IgG | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FCPAB | Result | Z0554 | C. pneumoniae IgA | C. pneumoniae IgA | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FCPAB | Result | Z0555 | C. pneumoniae IgM | C. pneumoniae IgM | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
FCPAB | Result | Z0556 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process